Conference - London, United Kingdom
Join us at the Adoptive T-Cell Therapy Congress, taking place March 15-16, 2016 to learn from, meet and network with 100+ scientists from academia, research and industry all working to develop state of the art T-cell therapies focusing on safety, efficacy and commercialisation.
Join the industry’s scientific and business leaders as we discuss adoptive T-cell therapies for cancer by looking at ways forward in improving efficiency and efficacy, case studies on liquid and solid tumours, scalability, manufacture and progress within industry regulation.
A global speaker faculty includes:
• Renier Brentjens, Memorial Sloan Kettering Cancer Centre (USA)
• Inge Marie Svane, University of Copenhagen (Denmark)
• Emma Morris, University College London (UK)
• Hans Stauss, Royal Free Hospital (UK)
• Weidong Ha, PLA General Hospital (China)
• Renier Brentjens, Memorial Sloan Kettering Cancer Centre (USA)
• Inge Marie Svane, University of Copenhagen (Denmark)
• Emma Morris, University College London (UK)
• Hans Stauss, Royal Free Hospital (UK)
• Weidong Ha, PLA General Hospital (China)
Organization: Kisaco Research
Tue, Mar 15, 2016 - Wed, Mar 16, 2016
Millennium Hotel London Knightsbridge
17 Sloane Street, Knightsbridge, London, United Kingdom
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
